The FDA has approved the Novavax COVID-19 vaccine, called Nuvaxovid, mainly for adults 65 or older, but people ages 12 to 64 with medical conditions that increase their risk of serious illness from ...

WASHINGTON (AP) — Robert F. Kennedy Jr. clinched the political support needed to become the nation’s top health official by ...

Novavax Inc. (NVAX) shares jumped 15% after the company received a long-awaited U.S. FDA approval for its COVID-19 vaccine. Shares of Regeneron Pharmaceuticals, Inc. (REGN) rose 0.4% after deciding to ...

US FDA approves Novavax’s BLA for Covid-19 vaccine, Nuvaxovid: Gaithersburg, Maryland Tuesday, May 20, 2025, 14:00 Hrs [IST] Novavax, Inc. announced that the US Food and Drug Ad ...

U.S. stocks settled mostly higher on Monday, with the Dow Jones index gaining more than 100 points during the session. Major ...

Southeast Asia sees a rise in COVID-19 cases due to new Omicron subvariants. Experts say most cases are mild, but precautions ...

Health-care companies rose as some beaten-down stocks recouped some of their losses. UnitedHealth Group rose by more than 7%, but remain more than one-third lower for the year to date. Similarly, ...

The LP.8.1 variant of the SARS-CoV-2 virus differs from the JN.1 family that previous vaccines had been designed to target, ...

JPMorgan analyst Eric Joseph reaffirmed an Underweight rating for Novavax Inc. (NASDAQ:NVAX) with a price target of $7. This ...